Health two-stage 2027

Opportunity snapshot

Collection

Horizon Europe

Source / programme

European Union / European Commission · Cluster 1 Health

Status

Forthcoming

Actionability

Forthcoming for new applicants

Record granularity

Umbrella Call

Verification date

17 Jul 2026

What the opportunity supports

This profile covers the Horizon Europe call or topic “Health two-stage 2027”. The official targeting includes: Prepare first-stage concept early; clinical trials/diagnostics require regulatory and recruitment strategy.

Thematic fit

Clinical and health-tech consortia

Egypt eligibility and applicant role

Egyptian private-sector entities can participate as funded beneficiaries and may coordinate unless a topic sets a narrower applicant or consortium condition.

Egyptian participation is subject to the live call, topic conditions, General Annexes and any strategic, security, ownership, control or establishment restrictions.

Best-fit applicants

Topics: NCD interventions, neurodegenerative clinical trials, AI biomarkers, portable point-of-care diagnostics.

Funding and instrument

Funding scale

Indicative EUR 5-10m per project

Instrument

RIA generally 100%; IA generally 70% for for-profit entities, unless the topic states otherwise.

Scale basis

Indicative

Co-financing

Topic-specific - Funding rate and own contribution vary by action type and topic

Access and co-financing

Topic-specific - Funding rate and own contribution vary by action type and topic

Submission timing

1. Openingtype=opening | stage=Opening | date=2027-02-10 | continuous=false | confirmed=true | estimated=false

Applicant positioning

Build the consortium around clinical and patient needs, regulatory science, data governance, validation sites and a credible adoption/reimbursement or procurement route.

Strategic fit and caveats

This is a call-level profile. Individual topic conditions, portal updates and the General Annexes remain controlling.

Priority

High

Priority rationale

for aligned industrial partners

Verification confidence

High

Horizon classification

Programme family

Horizon Europe

Pillar / programme part

Pillar II · Cluster 1 Health

Call / topic ID

HORIZON-HLTH-2027-02-two-stage

Call year

2027

Action type

RIA|IA

Record granularity

Umbrella Call

Egyptian private-sector role

Egyptian private-sector entities can participate as funded beneficiaries and may coordinate unless a topic sets a narrower applicant or consortium condition.

Coordination eligibility

Conditional / topic-specific

Access family

Consortium or funded partner

Consortium and beneficiary conditions

Mono-beneficiary status

No

Consortium conditions

Standard RIA/IA consortium; mono no

Funding and financial burden

Indicative project ticket

Indicative EUR 5-10m per project

Call budget

call budget EUR 186.6m

Expected awards

24

Funding rate

RIA generally 100%; IA generally 70% for for-profit entities, unless the topic states otherwise.

Co-financing

Topic-specific - Funding rate and own contribution vary by action type and topic

TRL and maturity

TRL range

Not specified

Maturity

Topic-specific; use the official topic conditions as the controlling maturity test.

Restrictions and screening

Strategic restrictions

No special restriction identified at profile level

Security restrictions

No special restriction identified at profile level

Ownership / control restrictions

No special restriction identified at profile level

Establishment restrictions

No special restriction identified at profile level

Screening note

No special restriction identified at profile level; topic conditions, the General Annexes and live portal still control

Source and verification

Adopted Horizon Europe 2026-2027 work programme and official programme source; live Funding & Tenders Portal recheck required